IC
Innealta Capital Portfolio holdings
AUM
$190M
1-Year Return
17.25%
This Quarter Return
-0.53%
1 Year Return
+17.25%
3 Year Return
+48.31%
5 Year Return
+75.43%
10 Year Return
–
AUM
$303M
AUM Growth
+$66.4M
(+28%)
Cap. Flow
+$67.9M
Cap. Flow
% of AUM
22.4%
Top 10 Holdings %
Top 10 Hldgs %
36.74%
Holding
1,848
New
1,738
Increased
31
Reduced
51
Closed
8
Top Buys
| 1 |
JPMorgan Core Plus Bond ETF
JCPB
|
+$13.8M |
| 2 |
The Communication Services Select Sector SPDR Fund
XLC
|
+$3.4M |
| 3 |
Janus Henderson AAA CLO ETF
JAAA
|
+$3.01M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$2.52M |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$2.5M |
Top Sells
| 1 |
SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$7.77M |
| 2 |
Financial Select Sector SPDR Fund
XLF
|
+$6.84M |
| 3 |
Energy Select Sector SPDR Fund
XLE
|
+$4.57M |
| 4 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$2.95M |
| 5 |
iShares MSCI Switzerland ETF
EWL
|
+$2.92M |
Sector Composition
| 1 | Financials | 2.68% |
| 2 | Industrials | 2.51% |
| 3 | Consumer Discretionary | 2.37% |
| 4 | Technology | 1.66% |
| 5 | Healthcare | 1.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
LXP Industrial Trust
LXP
$2.67B
| $757 | ﹤0.01% |
+83
| New | +$757 |
|
1327
Surmodics
SRDX
$459M
| $757 | ﹤0.01% |
+18
| New | +$757 |
|
1328
AdvanSix
ASIX
$554M
| $756 | ﹤0.01% |
+33
| New | +$756 |
|
1329
Dave & Buster's
PLAY
$769M
| $756 | ﹤0.01% |
+19
| New | +$756 |
|
|
AE
1330
DELISTED
Adams Resources & Energy Inc.
AE
| $756 | ﹤0.01% |
+27
| New | +$756 |
|
1331
Ducommun
DCO
$1.36B
| $755 | ﹤0.01% |
+13
| New | +$755 |
|
1332
AtriCure
ATRC
$1.75B
| $751 | ﹤0.01% |
+33
| New | +$751 |
|
1333
Kforce
KFRC
$550M
| $746 | ﹤0.01% |
+12
| New | +$746 |
|
1334
Ingevity
NGVT
$2.08B
| $743 | ﹤0.01% |
+17
| New | +$743 |
|
1335
Buckle
BKE
$3.06B
| $739 | ﹤0.01% |
+20
| New | +$739 |
|
1336
Upbound Group
UPBD
$1.46B
| $737 | ﹤0.01% |
+24
| New | +$737 |
|
1337
Agios Pharmaceuticals
AGIO
$2.07B
| $733 | ﹤0.01% |
+17
| New | +$733 |
|
1338
Altimmune
ALT
$324M
| $732 | ﹤0.01% |
+110
| New | +$732 |
|
1339
TG Therapeutics
TGTX
$5.05B
| $730 | ﹤0.01% |
+41
| New | +$730 |
|
1340
Simulations Plus
SLP
$280M
| $729 | ﹤0.01% |
+15
| New | +$729 |
|
1341
PTC
PTC
$24.5B
| $727 | ﹤0.01% |
+4
| New | +$727 |
|
1342
Cogent Biosciences
COGT
$1.78B
| $725 | ﹤0.01% |
+86
| New | +$725 |
|
1343
Healthpeak Properties
DOC
$12.5B
| $725 | ﹤0.01% |
+37
| New | +$725 |
|
1344
Roku
ROKU
$14B
| $719 | ﹤0.01% |
+12
| New | +$719 |
|
1345
Accel Entertainment
ACEL
$935M
| $718 | ﹤0.01% |
+70
| New | +$718 |
|
1346
Transcat
TRNS
$705M
| $718 | ﹤0.01% |
+6
| New | +$718 |
|
1347
Schrodinger
SDGR
$1.34B
| $716 | ﹤0.01% |
+37
| New | +$716 |
|
1348
Jack in the Box
JACK
$345M
| $713 | ﹤0.01% |
+14
| New | +$713 |
|
1349
Harrow
HROW
$1.44B
| $710 | ﹤0.01% |
+34
| New | +$710 |
|
1350
EverQuote
EVER
$849M
| $709 | ﹤0.01% |
+34
| New | +$709 |
|